Bioventus Inc.
BVS
$8.97
-$0.18-1.97%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.73M | 7.59M | -731.00K | -33.87M | -36.13M |
| Total Depreciation and Amortization | 21.30M | 17.30M | 18.18M | 19.22M | 19.14M |
| Total Amortization of Deferred Charges | 3.63M | 5.58M | 5.58M | 5.58M | 5.58M |
| Total Other Non-Cash Items | 40.85M | 47.71M | 46.51M | 62.77M | 61.99M |
| Change in Net Operating Assets | -13.84M | -22.16M | -33.29M | -28.22M | -11.78M |
| Cash from Operations | 74.67M | 56.03M | 36.25M | 25.47M | 38.80M |
| Capital Expenditure | -2.56M | -2.56M | -2.15M | -1.54M | -1.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -686.00K | 23.99M | 23.99M | 24.68M | 24.68M |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -709.00K |
| Cash from Investing | -3.25M | 21.44M | 21.85M | 23.14M | 22.96M |
| Total Debt Issued | 76.91M | 76.91M | 15.00M | 15.00M | -- |
| Total Debt Repaid | -54.05M | -73.57M | -58.26M | -61.53M | -59.58M |
| Issuance of Common Stock | 2.07M | 2.67M | 3.12M | 2.42M | 2.44M |
| Repurchase of Common Stock | -9.00K | -9.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.06M | -82.55M | -16.07M | -5.28M | 2.56M |
| Cash from Financing | -62.14M | -76.55M | -56.21M | -49.39M | -54.58M |
| Foreign Exchange rate Adjustments | 371.00K | -1.83M | -965.00K | -1.59M | -2.56M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.66M | -910.00K | 916.00K | -2.37M | 4.62M |